Safety Alerts Saves Lives
Safety Alerts  
Home Privacy About Us Contact Us Change Preferences
" "
Safety Alerts
September 14, 1999

Cardioquin Tablets (Quinidine - Polygalcturonate) Recalled by The P.F. Laboratories, Inc.

Totowa, NJ (SafetyAlerts) - The Food and Drug Administration (FDA) today reported that The P.F. Laboratories, Inc. is recalling Cardioquin Tablets because of tablet discoloration (darker-due to oxidation product).

Cardioquin Tablets (Quinidine Polygalcturonate), 275 mg, in 100 tablet bottles, Rx used to treat significant cardiac arrhythmias.NDC #0034-5470-80.

Recall #D-412-9.  Class II

Lot #77L1 EXP 5/2004.

The P.F. Laboratories, Inc., Totowa, New Jersey (responsible firm)

The Purdue Frederick Company, Norwalk, Connecticut, by telephone on June 16 and 17, 1999, and by fax on June 18, 1999. Firm- initiated recall ongoing.


360 bottles were distributed; firm estimated that 122 bottles remained on market at time of recall initiation.

Safety Alerts compiles comprehensive safety recall information for the United States. SafeMail is a free email service to warn consumers of faulty products and contaminated foods. For complete information regarding current recalls, past recalls and timely product warning notification visit:



The information contained herein has been obtained from sources that the Company believes to be reliable, however, the Company has not independently verified or confirmed the information and the recipient acknowledges that no representations or warranties are being made in connection with the use of the information.